Versuchen GOLD - Frei

Funding, Lack of Talent Trip Up India's AI Leadership Goal

Mint Chennai

|

August 19, 2025

While more AI startups are seeking funds from VC investors, they are still very small in scale

- Jas Bardia & Shouvik Das

Elusive big-ticket private funding, low research and development (R&D) investments and a shortage of engineers with specialized skills continue to threaten India's ambition to become a global leader in artificial intelligence (AI).

Last week, a report by industry body National Association of Software and Services Companies (Nasscom) said that while more and more AI startups are seeking funds from venture capital investors, they are still very small in scale. In the first six months of this calendar year, 87% of the $122 million invested by VCs in AI startups went into early-stage investments.

Indian ventures, according to the report, raised less than $16 million in late funding in the first six months of this year. In comparison, during the same period, at least 21 AI startups in the US have raised $100 million or more each to scale up development. This is in addition to AI behemoths Anthropic and OpenAI raising billion-dollar rounds. A total of $4.9 billion was raised by the American startups seeking large funds for AI training and scaling, making India's large investments insignificant, if not inconsequential.

WEITERE GESCHICHTEN VON Mint Chennai

Mint Chennai

Mint Chennai

Lenskart wants artificial intelligence to test your eyes

It expects AI-enabled eye testing to become the default foundational layer of eyecare delivery

time to read

3 mins

January 13, 2026

Mint Chennai

Mint Chennai

More companies to take a hit as labour codes debut

Reworked gratuity and leave encashments spell additional expenses for India Inc

time to read

2 mins

January 13, 2026

Mint Chennai

HC lifts ban on Zydus cancer biosimilar till patent expiry

In a relief for Zydus Lifesciences, a division bench of the Delhi High Court on Monday allowed the drugmaker to sell and market its biosimilar of the anticancer drug nivolumab in India, citing public interest.

time to read

2 mins

January 13, 2026

Mint Chennai

Trump’s investigation of Powell is also a warning to the next Fed chair

The criminal investigation into Federal Reserve Chair Jerome Powell isn’t ultimately about the Fed’s headquarters, or Powell, or even interest rates.

time to read

3 mins

January 13, 2026

Mint Chennai

Mint Chennai

States flag Almont-Kid syrup as tests find contaminants

Syrup found ‘Not of Standard Quality’ with contaminants like toxic ethylene glycol

time to read

1 mins

January 13, 2026

Mint Chennai

Mint Chennai

India at 100: Our choices today will define the next two decades

India's 2047 ambition is not guaranteed but achievable if we address all the potential pitfalls along our development path

time to read

4 mins

January 13, 2026

Mint Chennai

Now, inheritance works without probate—but why it still matters

Heirs can now act on a valid will without court cases, easing delays and unlocking assets in undisputed cases

time to read

6 mins

January 13, 2026

Mint Chennai

Why VCs have a new deep-tech playbook

where fundraising starts to drag,\" said Chand.

time to read

1 min

January 13, 2026

Mint Chennai

TCS, HCLTech deliver Q3 revenue surprise

clearer.

time to read

2 mins

January 13, 2026

Mint Chennai

Mint Chennai

US productivity is rising and it risks warping monetary policy

America's neutral rate ought to be going up but will the Fed listen?

time to read

3 mins

January 13, 2026

Listen

Translate

Share

-
+

Change font size